Market Research Logo

ImpediMed Ltd (IPD) - Financial and Strategic SWOT Analysis Review

ImpediMed Ltd (IPD) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

ImpediMed Ltd (ImpediMed) is a manufacturer of bioimpedance devices with a focus on medical applications in the fluid status domain. It designs, manufactures and sells bioimpedance spectroscopy (BIS) devices for assessing lymphoedema and body composition. The major products of the company include BIS device to assess early signs of lymphedema; single channel, tetra polar BIS device to estimate total body water, extracellular fluid and intracellular fluid; body composition analysis device, and a spectroscopy (BIS) device for veterinary applications. Its products are based on BIS and bioimpedance analysis platform technologies and they obtain readings from a wide frequency range to improve the accuracy of bioimpedance analysis. The company sells its products through distributors in Australia, Europe and the US. ImpediMed is headquartered in Brisbane, Queensland, Australia.

ImpediMed Ltd Key Recent Developments

Aug 23,2017: ImpediMed: Financial Year Ended 30 June 2017
Jul 24,2017: APPENDIX 4C – Quarter Ended 30 June 2017
Jun 21,2017: SOZO obtains CE Mark for Heart Failure Patient Monitoring
Apr 24,2017: SOZO Shipped to Vanderbilt to Commence At-Home Study for Lymphoedema
Mar 07,2017: First SOZO Device Placed at Scripps Health for CHF StudyKey benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
ImpediMed Ltd - Key Facts
ImpediMed Ltd - Key Employees
ImpediMed Ltd - Key Employee Biographies
ImpediMed Ltd - Major Products and Services
ImpediMed Ltd - History
ImpediMed Ltd - Company Statement
ImpediMed Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
ImpediMed Ltd - Business Description
ImpediMed Ltd - SWOT Analysis
SWOT Analysis - Overview
ImpediMed Ltd - Strengths
ImpediMed Ltd - Weaknesses
ImpediMed Ltd - Opportunities
ImpediMed Ltd - Threats
ImpediMed Ltd - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
ImpediMed Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017
ImpediMed Ltd, Medical Equipment, Deals By Type, 2011 to YTD 2017
ImpediMed Ltd, Recent Deals Summary
Section 5 – Company’s Recent Developments
Aug 23, 2017: ImpediMed: Financial Year Ended 30 June 2017
Jul 24, 2017: APPENDIX 4C – Quarter Ended 30 June 2017
Jun 21, 2017: SOZO obtains CE Mark for Heart Failure Patient Monitoring
Apr 24, 2017: SOZO Shipped to Vanderbilt to Commence At-Home Study for Lymphoedema
Aug 11, 2016: SOZO Launched-First Product for Health and Wellness Markets
Aug 09, 2016: FDA Releases Important Information Focused on Digital Health
Aug 08, 2016: ImpediMed Changes to Board of Directors
Jul 29, 2016: Impedimed To Present At Bioshares Biotech Summit 2016
Jul 20, 2016: Strategic Relationship with Redox to Expand EHR Integration Capabilities
Jul 18, 2016: Vanderbilt to Begin Testing Next Generation Device
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
ImpediMed Ltd, Key Facts
ImpediMed Ltd, Key Employees
ImpediMed Ltd, Key Employee Biographies
ImpediMed Ltd, Major Products and Services
ImpediMed Ltd, History
ImpediMed Ltd, Other Locations
ImpediMed Ltd, Subsidiaries
ImpediMed Ltd, Key Competitors
ImpediMed Ltd, Ratios based on current share price
ImpediMed Ltd, Annual Ratios
ImpediMed Ltd, Annual Ratios (Cont...1)
ImpediMed Ltd, Interim Ratios
ImpediMed Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017
ImpediMed Ltd, Medical Equipment, Deals By Type, 2011 to YTD 2017
ImpediMed Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
ImpediMed Ltd, Performance Chart (2013 - 2017)
ImpediMed Ltd, Ratio Charts
ImpediMed Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017
ImpediMed Ltd, Medical Equipment, Deals by Type, 2011 to YTD 2017

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report